Cargando…
1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy
Autores principales: | Zambelli, A., Fotia, V., Bosetti, T., Negrini, G., di Croce, A., Moro, C., Poletti, P.L., Bettini, A.C., Arnoldi, E., Messina, C., Merelli, B., Callegaro, A.P., Chiudinelli, L., Mosconi, S., Tondini, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506461/ http://dx.doi.org/10.1016/j.annonc.2020.08.1741 |
Ejemplares similares
-
Prevalence and Clinical Impact of SARS‐CoV‐2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID‐19 Pandemic
por: Zambelli, Alberto, et al.
Publicado: (2021) -
Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
por: Servín-Caamaño, A., et al.
Publicado: (2020) -
Aspartate aminotransferase as predictor of severity in SARSCoV-2 infection: linear regression model
por: Servín-Caamaño, A., et al.
Publicado: (2020) -
Exploring the acceptability of controlled human infection with SARSCoV2—a public consultation
por: Gbesemete, D., et al.
Publicado: (2020) -
Is SARSCoV-2 nasopharyngeal swab still a gold standard in children?
por: Marino, Silvia, et al.
Publicado: (2020)